ArticleVaccine2020

BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.

Yusuke Tomita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.